Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure.
Semmler G, Alonso López S, Pons M, Lens S, Dajti E, Griemsmann M, Zanetto A, Burghart L, Hametner-Schreil S, Hartl L, Manzano M, Rodriguez-Tajes S, Zanaga P, Schwarz M, Gutierrez ML, Jachs M, Pocurull A, Polo B, Ecker D, Mateos B, Izquierdo S, Real Y, Ahumada A, Bauer DJM, Mauz JB, Casanova-Cabral M, Gschwantler M, Russo FP, Azzaroli F, Maasoumy B, Reiberger T, Forns X, Genesca J, Bañares R, Mandorfer M; cACLD-SVR Study Group.
Semmler G, et al. Among authors: schwarz m.
J Hepatol. 2024 Mar 21:S0168-8278(24)00198-3. doi: 10.1016/j.jhep.2024.03.015. Online ahead of print.
J Hepatol. 2024.
PMID: 38521170
Free article.